NPI: 1386690956 · LEXINGTON, MS 39095 · 261QE0700X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 28,540 | $576K |
| 2019 | 29,547 | $554K |
| 2020 | 26,525 | $430K |
| 2021 | 18,509 | $274K |
| 2022 | 13,458 | $308K |
| 2023 | 6,873 | $412K |
| 2024 | 5,570 | $339K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | 41,819 | 3,756 | $2.09M | |
| Q4081 | Epoetin alfa, 100 units esrd | 38,463 | 2,368 | $465K |
| J0604 | Cinacalcet, esrd on dialysis | 706 | 387 | $138K |
| 83970 | 2,172 | 1,943 | $61K | |
| A4657 | Syringe w/wo needle | 6,445 | 2,845 | $39K |
| J1756 | Iron sucrose injection | 7,263 | 1,867 | $33K |
| 82728 | 1,556 | 1,437 | $17K | |
| J1270 | Injection, doxercalciferol | 21,407 | 2,043 | $15K |
| 83550 | 1,380 | 1,306 | $11K | |
| 83540 | 1,596 | 1,464 | $8K | |
| 85041 | 2,041 | 1,879 | $4K | |
| 85048 | 2,045 | 1,881 | $3K | |
| 90674 | 114 | 111 | $2K | |
| 90662 | 56 | 53 | $2K | |
| 85045 | 440 | 404 | $1K | |
| 82746 | 61 | 60 | $902.40 | |
| J0887 | Epoetin beta esrd use | 615 | 321 | $0.00 |
| G0499 | Hepb screen high risk indiv | 692 | 471 | $0.00 |
| G0008 | Admin influenza virus vac | 151 | 146 | $0.00 |